A doctor inspecting a vile

Transforming Heart, Lung and Vascular Care

We’re ranked number six in the U.S. for enrollment in trials for the heart device Heartmate III, the gold standard for LVAD technology without radiation – and we’re innovating with new assistant devices like the Mitral Valve Clip, TAVR, Watchman™ and more. Access expertise from one of the finest programs in the state with the only pulmonary hypertension program and the only heart and lung transplant center in Central Florida.

Recent News

Ensuring Early and Accurate Diagnosis of Cardiac Amyloidosis to Initiate Timely Multidisciplinary Treatment
Aveir DR i2i clinical tria
AdventHealth First in Central Florida to Implant Dual-Chamber Leadless Pacemaker as Part of AVEIR DR i2i Clinical Trial
AdventHealth First in Florida to Successfully Implant Thoraflex™ Hybrid Device in Patient with Complex Aortic Arch Dissection
Accola - Mitrus Valve
AdventHealth Among First in the U.S. to Use New MITRIS RESILIA Bioprosthetic Mitral Replacement Valve with Anti-calcification Technology
Society of Thoracic Surgery Awards Three AdventHealth Campuses Highest Quality Rating for Coronary Artery Bypass Graft Surgical Outcomes
A 3D illustration of the heart and veins around the respiratory system

Heart, Lung and Vascular Newsletters

Read the latest in Heart, Lung and Vascular from AdventHealth Heart, Lung and Vascular Institute, including clinical innovation, peer-to-peer insights, rare cases and more.

Highlighted HLVI Trials

Our relentless drive to bring AdventHealth patients the most effective treatment options is why we’re ranked number six in the U.S. for enrollment in trials for the heart device Heartmate III, the gold standard for LVAD technology without radiation.

View All Cardiovascular Trials

3 items. To interact with these items, press Control-Option-Shift-Right Arrow
  • Now Enrolling

    DIAMOND AF II - DiamondTemp System for the Treatment of Persistent Atrial Fibrillation

    Principal Investigator:

    Usman Siddiqui, MD

  • Now Enrolling

    Star-T: Prospective, Multi center, Double-blind, Randomized, Study to Evaluate Reduction in Postoperative Bleeding by Removal of Ticagrelor with the Intraoperative use of the DrugSorb-ATR Device in Patients Undergoing on-pump Cardiothoracic Surgery within Two Days of Ticagrelor Discontinuation

    Principal Investigator:

    Kevin Accola, MD

  • Now Enrolling

    MODULAR ATP: A prospective, non-randomized, multi-site study, single-arm, global study utilizing performance goals to demonstrate safety, performance, and effectiveness of the EMPOWER System and mCRM Modular Therapy System.

    Principal Investigator:

    Naushad Shaik, MD

Physicians in operating room

Nationally Ranked Cardiac Experts

Our team of nationally-ranked cardiologists, cardiovascular surgeons, and thoracic surgeons, comes highly regarded for treating complex cases.